Spots Global Cancer Trial Database for Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer
Official Title: Non-interventional Observational Study of Helical Tomotherapy for Oligometastatic Colorectal Cancer
Study ID: NCT00807313
Interventions
Study Description
Brief Summary: Patients with oligometastatic colorectal cancer (5 metastases or less) receive a combination of systemic treatment and often local treatment, such as surgery, radiofrequency ablation and more recently stereotactic body radiotherapy. The aim of this study is to register the results and side effects of stereotactic body radiotherapy (SBRT) by means of helical tomotherapy in the treatment of oligometastatic colorectal cancer. The trial has two cohorts. Patients in cohort I get consolidation SBRT after best response on first line chemotherapy. Patients in cohort II get SBRT when there is progression under, or no indication for (further) chemotherapy. The primary endpoint is to evaluate the metabolic complete remission rate three months after the start of radiotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie, Brussels, , Belgium
Contact Details
Name: Mark De Ridder, MD, PhD
Affiliation: UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
